Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8IYB7: Variant p.Arg576His

DIS3-like exonuclease 2
Gene: DIS3L2
Feedback?
Variant information Variant position: help 576 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Histidine (H) at position 576 (R576H, p.Arg576His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help Disrupted by a t(2;7)(q37.1;q21.3) chromosomal translocation found in a patient suffering from Marfanoid habitus and skeletal anomalies. However, its absence does not seem to be the cause of the disease. Additional information on the polymorphism described.
Variant description: help Found in a patient with Wilms tumor; likely pathogenic; does not suppress anchorage-independent cell growth. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 576 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 885 The length of the canonical sequence.
Location on the sequence: help LAFTLDHETGLPQGCHIYEY R ESNKLVEEFMLLANMAVAHK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LAFTLDHETGLPQGCHIYEYRESNKLVEEFMLLANMAVAHK

Mouse                         LAFTLDHETGLPQGCHIYEYRDSNKLVEEFMLLANMAVAHK

Xenopus tropicalis            LTFTLDKESGLPQGCYIYQYRDSNKLVEEFMLLANMAVAHH

Caenorhabditis elegans        LKFALD-EDKKPQGVSIYEIKDSNKLVEEFMLLANMEVAKK

Fission yeast                 LKFQLD-EYGMPNKCEVYEQTDANHLIEEFMLLANRSVAEH

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 885 DIS3-like exonuclease 2
Alternative sequence 250 – 885 Missing. In isoform 4.
Alternative sequence 357 – 885 Missing. In isoform 5.
Alternative sequence 528 – 603 AVLNLHGIAKQLRQQRFVDGALRLDQLKLAFTLDHETGLPQGCHIYEYRESNKLVEEFMLLANMAVAHKIHRAFPE -> QNADKDGAAHLQASHSPSAEDAEAQPSTEERLPETRGICDRDPDTRLFFLQQQSRVLEAKPQNTIRVEEQTTQLQI. In isoform 3.



Literature citations
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.
Astuti D.; Morris M.R.; Cooper W.N.; Staals R.H.; Wake N.C.; Fews G.A.; Gill H.; Gentle D.; Shuib S.; Ricketts C.J.; Cole T.; van Essen A.J.; van Lingen R.A.; Neri G.; Opitz J.M.; Rump P.; Stolte-Dijkstra I.; Muller F.; Pruijn G.J.; Latif F.; Maher E.R.;
Nat. Genet. 44:277-284(2012)
Cited for: SUBCELLULAR LOCATION; VARIANT PRLMNS TYR-489; VARIANTS GLY-483 AND HIS-576; CHARACTERIZATION OF VARIANTS GLY-483 AND HIS-576;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.